Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) named Kare Schultz to the position of chief executive officer. The stock price surged $3.00 to close at $18.50.
Teva names new CEO
September 11, 2017 at 19:08 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.